Le mode conseil est activé Arrêter

Emergent Biosolutions, ordinary share
US29089Q1058, EBS

Ajouter une action à la Liste de suivi
Sélectionnez tout Réinitialiser tout
Emergent Biosolutions, pays — États-Unis
Aucunes données de trading
Représentation des données graphique | tableau
Source d'information - PJSC "MOEX". Toute autre diffusion des informations MOEX est interdite sans l'accord préalable de PJSC "MOEX".
Source d'information - PJSC "MOEX". Toute autre diffusion des informations MOEX est interdite sans l'accord préalable de PJSC "MOEX".
de
à
ADD-IN
Add-in Cbonds API
bond data api
Il faut s'enregistrer
Envoyer la demande d'accès accès
Plus de 2 500 éléments ont été trouvés, veuillez préciser votre demande
Pas de données sur la période choisie

Dernières cotations

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Émetteur

Profil
Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. ...
Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. The Company operates in two divisions: BioDefense Division and BioSciences Division. It derived substantially all of its product revenues from sales of BioThrax to the United States government, specifically and the United States Department of Health and Human Services (HHS), as well as the United States Department of Defense (DoD).
Montrer tout Cacher
  • Emetteur
  • Nom complet de l'emprunteur / émetteur
    Emergent Biosolutions Inc
  • Secteur (industrie)
    Production de médicaments et biotechnologies

Rapports IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Indicateurs

Actualités

23/04/2024 Emergent Biosolutions: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
13/03/2024 S&P Global Ratings downgrades Local Currency LT credit rating of Emergent Biosolutions to "CCC+"
13/03/2024 S&P Global Ratings downgrades Foreign Currency LT credit rating of Emergent Biosolutions to "CCC+"
29/02/2024 Emergent Biosolutions: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Regulation Fd Disclosure, Financial Statements And Exhibits
20/02/2024 Emergent Biosolutions: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
Toutes les actualités de l'organisation

Obligations nationales et internationales de l'émetteur

Détenteurs

Leaders de l'industrie

Vous devez vous inscrire pour y accéder.